journal article·2024Open access

Generation of nanobodies with conformational specificity for tau oligomers that recognize tau aggregates from human Alzheimer's disease samples

Nikki McArthur, Jay D. Squire, Ogechukwu J. Onyeachonam, Nemil N. Bhatt, Cynthia Jerez, Abigail L. Holberton, Peter M. Tessier, Levi B. Wood, Rakez Kayed, Ravi S. Kane

Biomaterials Science· Volume 12· Issue 23

Abstract

Tauopathies are neurodegenerative diseases that involve tau misfolding and aggregation in the brain. These diseases, including Alzheimer's disease (AD), are some of the least understood and most difficult to treat neurodegenerative disorders. Antibodies and antibody fragments that target tau oligomers, which are especially toxic forms of tau, are promising options for immunotherapies and diagnostic tools for tauopathies. In this study, we have developed conformational, tau oligomer-specific nanobodies, or single-domain antibodies. We demonstrate that these nanobodies, OT2.4 and OT2.6, are highly specific for tau oligomers relative to tau monomers and fibrils. We used epitope mapping to verify that these nanobodies bind to discontinuous epitopes on tau and to support the idea that they interact with a conformation present in the oligomeric, and not monomeric or fibrillar, forms of tau. We show that these nanobodies interact with tau oligomers in brain samples from AD patients and from healthy older adults with primary age-related tauopathy. Our results demonstrate the potential of these nanobodies as tau oligomer-specific binding reagents and future tauopathy therapeutics and diagnostics.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Alzheimer's disease research and treatments · Protein Structure and Dynamics · Computational Drug Discovery Methods

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA

Mitchell Center for Neurodegenerative Disease, University of Texas Medical Branch, Galveston, Texas 77555, USA

Department of Neurology, University of Texas Medical Branch, Galveston, Texas 77555, USA

George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA

Department of Chemical Engineering, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Ann Arbor, MI 48109, USA

Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA

Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA

Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA

Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia 30332, USA

Funding

National Institutes of Health · National Science Foundation

References (50)

Show source-provided references
1. Zhang · Mol. Neurodegener. · 2022 · 17 · 110.1186/S13024-022-00533-Z ↗
2. Song · Transl. Neurodegener. · 2022 · 11 · 110.1186/S40035-022-00292-3 ↗
3. Guo · Ageing Res. Rev. · 2024 · 94 · 10219210.1016/J.ARR.2024.102192 ↗
4. Castillo-Carranza · J. Neurosci. · 2014 · 34 · 426010.1523/JNEUROSCI.3192-13.2014 ↗
5. Castillo-Carranza · J. Alzheimer’s Dis. · 2014 · 40 · S9710.3233/JAD-132477 ↗
6. He · J. Biol. Chem. · 2021 · 296 · 10024110.1074/jbc.RA120.015327 ↗
7. Henderson · Neurobiol. Dis. · 2020 · 136 · 10471210.1016/J.NBD.2019.104712 ↗
8. G.Gallardo and D. M.Holtzman , Amyloid-β and Tau at the Crossroads of Alzheimer's Disease , in Advances in Experimental Medicine and Biology , Springer , 2019 , vol. 1184 , pp. 187–203 . 10.1007/978-981-32-9358-8_1610.1007/978-981-32-9358-8_16 ↗
9. Roda · Neural Regener. Res. · 2022 · 17 · 166610.4103/1673-5374.332127 ↗
10. Zhang · Signal Transduction Targeted Ther. · 2023 · 8 · 110.1038/s41392-023-01484-7 ↗
11. Guo · Ageing Neurodegener. Dis. · 2022 · 2 · 1110.20517/and.2022.16 ↗
12. Congdon · Nat. Rev. Neurol. · 2023 · 19 · 71510.1038/s41582-023-00883-2 ↗
13. Niewiadomska · Life · 2021 · 11 · 110.3390/LIFE11010028 ↗
14. M. D. C.Cárdenas-Aguayo , L.Gómez-Virgilio , S.DeRosa and M. A.Meraz-Ríos , The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology , in ACS Chemical Neuroscience . American Chemical Society , 2014 , pp. 1178–1191 . 10.1021/cn500148z10.1021/cn500148z ↗
15. Shafiei · Front. Aging Neurosci. · 2017 · 910.3389/FNAGI.2017.00083 ↗
16. Ghag · Protein Sci. · 2018 · 27 · 190110.1002/PRO.3499 ↗
17. Gerson · ACS Chem. Neurosci. · 2014 · 5 · 75210.1021/CN500143N ↗
18. Jicha · J. Neurosci. Res. · 1997 · 48 · 12810.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E ↗
19. Kayed · Mol. Neurodegener. · 2010 · 5 · 110.1186/1750-1326-5-57 ↗
20. Combs · Neurobiol. Dis. · 2016 · 94 · 1810.1016/J.NBD.2016.05.016 ↗
21. Abskharon · J. Biol. Chem. · 2020 · 295 · 1066210.1074/JBC.RA120.013638 ↗
22. Patterson · J. Biol. Chem. · 2011 · 286 · 2306310.1074/jbc.M111.237974 ↗
23. H.-C.Tai , H.-T.Ma , S.-C.Huang , M.-F.Wu , C.-L.Wu , Y.-T.Lai , Z.-L.Li , R.Margolin , A. J.Intorcia , G. E.Serrano , T. G.Beach , M.Nallani , B.Navia , M.-K.Jang and C.-Y.Tai , The Tau Oligomer Antibody APNmAb005 Detects Early-Stage Pathological Tau Enriched at Synapses and Rescues Neuronal Loss in Long-Term Treatments. 10.1101/2022.06.24.49745210.1101/2022.06.24.497452 ↗
24. Steeland · Drug Discovery Today · 2016 · 21 · 107610.1016/J.DRUDIS.2016.04.003 ↗
25. Bao · EJNMMI Res. · 2021 · 11 · 110.1186/S13550-021-00750-5 ↗
26. McArthur · Biotechnol. Prog. · 2024 · e346310.1002/BTPR.3463 ↗
27. Zupancic · Front. Immunol. · 2023 · 14 · 116408010.3389/FIMMU.2023.1164080 ↗
28. A. A.Desai , J. M.Zupancic , H.Trzeciakiewicz , J. E.Gerson , K. N.DuBois , M. E.Skinner , L. M.Sharkey , N.McArthur , S. P.Ferris , N. N.Bhatt , E. K.Makowski , M. D.Smith , H.Chen , J.Huang , C.Jerez , R. S.Kane , N. M.Kanaan , H. L.Paulson and P. M.Tessier , Flow Cytometric Isolation of Drug-like Conformational Antibodies Specific for Amyloid Fibrils, BioRxiv , 2023, 2023.07.04.547698. 10.1101/2023.07.04.54769810.1101/2023.07.04.547698 ↗
29. Danis · Mol. Ther. · 2022 · 30 · 148410.1016/j.ymthe.2022.01.009 ↗
30. Dupré · ACS Chem. Neurosci. · 2019 · 10 · 399710.1021/acschemneuro.9b00217 ↗
31. Li · J. Controlled Release · 2016 · 243 · 110.1016/J.JCONREL.2016.09.019 ↗
32. Abskharon · Proc. Natl. Acad. Sci. U. S. A. · 2023 · 120 · e230025812010.1073/pnas.2300258120 ↗
33. Jiang · Sci. Adv. · 2023 · 9 · eadf377510.1126/SCIADV.ADF3775 ↗
34. Congdon · EBioMedicine · 2022 · 84 · 10424910.1016/j.ebiom.2022.104249 ↗
35. De Leiris · J. Transl. Med. · 2024 · 22 · 110.1186/S12967-024-04987-1 ↗
36. Lafaye · Mol. Immunol. · 2009 · 46 · 69510.1016/J.MOLIMM.2008.09.008 ↗
37. Bigi · Alzheimers Res. Ther. · 2024 · 16 · 110.1186/S13195-023-01361-Z ↗
38. Kasturirangan · Neurobiol. Aging · 2012 · 33 · 132010.1016/J.NEUROBIOLAGING.2010.09.020 ↗
39. Lasagna-Reeves · FASEB J. · 2012 · 26 · 194610.1096/fj.11-199851 ↗
40. McMahon · Nat. Struct. Mol. Biol. · 2018 · 25 · 28910.1038/s41594-018-0028-6 ↗
41. U.Sengupta , M.Carretero-Murillo and R.Kayed , Preparation and Characterization of Tau Oligomer Strains , in Methods in Molecular Biology , Humana Press Inc. , 2018 , vol. 1779 , pp. 113–146 . 10.1007/978-1-4939-7816-8_910.1007/978-1-4939-7816-8_9 ↗
42. Lasagna-Reeves · Biochemistry · 2010 · 49 · 1003910.1021/bi1016233 ↗
43. N.Gera , M.Hussain and B. M.Rao , Protein Selection Using Yeast Surface Display. Methods , Academic Press , 2013 , pp. 15–26 . 10.1016/j.ymeth.2012.03.01410.1016/j.ymeth.2012.03.014 ↗
44. Fitzpatrick · Nature · 2017 · 547 · 18510.1038/nature23002 ↗
45. Ward · J. Alzheimer's Dis. · 2013 · 37 · 59310.3233/JAD-131235 ↗
46. Sun · Comput. Math Methods Med. · 2013 · 2013 · 94634610.1155/2013/943636 ↗
47. Meraz-Ríos · J. Neurochem. · 2010 · 112 · 135310.1111/J.1471-4159.2009.06511.X ↗
48. Kolarova · J. Alzheimer's Dis. · 2017 · 58 · 47110.3233/JAD-170048 ↗
49. Maeda · Neurosci. Res. · 2006 · 54 · 19710.1016/J.NEURES.2005.11.009 ↗
50. Schumacher · Angew. Chem., Int. Ed. · 2018 · 57 · 231410.1002/ANIE.201708459 ↗